Finally, a small number of recent animal and in vitro studies have reported promising results regarding the therapeutic potential of certain ncRNAS such as the lncRNAs NDIME and IFNG-AS1 [55,57], the synthetic antisense lncRNA SINEUP-CHD8 [65] and a miR-301a inhibitor [59] for autism and a group of short rRNAs for fetal alcohol spectrum disorders [26]. This evidence concerns the gene MIR9-2HG and autism.